To explore the mechanism of anti-NAFLD activity of TARAP, we assessed the mRNA and protein expression of ACC, FAS, and CPT in liver tissues using RT-PCR assay and immunohistochemistry analysis (IHC), respectively. Here, FAS is linked to metabolic dysfunction-associated steatotic liver disease.